Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating activities:      
Net income $ 153 $ 523 $ 1,104
Less: Income from discontinued operations, net of tax (118) (12) (49)
Income from continuing operations 35 511 1,055
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (83) (67) (143)
Unrealized losses on fair value adjustments to Venator investment, net 5 12 28
Cash received from return on investment in unconsolidated subsidiary 59 71 57
Depreciation and amortization 278 281 278
Noncash lease expense 68 63 64
Gain on disposal of businesses/assets 0 0 (28)
Loss on early extinguishment of debt 0 0 27
Noncash restructuring and impairment charges 11 6 18
Deferred income taxes (10) 89 (39)
Stock-based compensation 28 29 30
Other, net 19 (39) (11)
Changes in operating assets and liabilities:      
Accounts and notes receivable 103 146 (313)
Inventories 125 (6) (342)
Receivable associated with the Albemarle Settlement 0 333 (333)
Other current assets 30 (44) 39
Other noncurrent assets 60 (52) (189)
Accounts payable (224) (84) 346
Accrued liabilities (31) (304) 296
Other noncurrent liabilities (222) (53) 75
Net cash provided by operating activities from continuing operations 251 892 915
Net cash (used in) provided by operating activities from discontinued operations (42) 22 37
Net cash provided by operating activities 209 914 952
Investing activities:      
Capital expenditures (230) (272) (326)
Cash received from sale of businesses, net 544 0 43
Acquisition of businesses, net of cash acquired 0 0 (245)
Insurance proceeds for recovery of property damage 0 5 8
Other, net (5) 7 12
Net cash provided by (used in) investing activities from continuing operations 309 (260) (508)
Net cash used in investing activities from discontinued operations (4) (19) (16)
Net cash provided by (used in) investing activities 305 (279) (524)
Financing activities:      
Net (repayments) borrowings on revolving loan facilities (51) 219 (8)
Proceeds from issuance of long-term debt 0 0 447
Repayments of long-term debt (11) (12) (990)
Costs of early extinguishment of debt 0 0 (26)
Dividends paid to common stockholders (169) (171) (159)
Distributions paid to noncontrolling interests (36) (16) (40)
Repurchase of common stock (349) (1,005) (200)
Repurchase and cancellation of stock awards (10) (14) (7)
Proceeds from issuance of common stock 5 6 10
Other, net 1 (1) (4)
Net cash used in financing activities (620) (994) (977)
Effect of exchange rate changes on cash (8) (28) (3)
Decrease in cash and cash equivalents (114) (387) (552)
Cash and cash equivalents at beginning of period 654 1,041 1,593
Cash and cash equivalents at end of period 540 654 1,041
Supplemental cash flow information:      
Cash paid for interest 68 66 82
Cash paid for income taxes 97 194 106
Huntsman International LLC [Member]      
Operating activities:      
Net income 155 524 1,107
Less: Income from discontinued operations, net of tax (118) (12) (49)
Income from continuing operations 37 512 1,058
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Equity in income of investment in unconsolidated affiliates (83) (67) (143)
Unrealized losses on fair value adjustments to Venator investment, net 5 12 28
Cash received from return on investment in unconsolidated subsidiary 59 71 57
Depreciation and amortization 278 281 278
Noncash lease expense 68 63 64
Gain on disposal of businesses/assets 0 0 (28)
Loss on early extinguishment of debt 0 0 27
Noncash restructuring and impairment charges 11 6 18
Deferred income taxes (10) 91 (40)
Other, net 18 (37) (13)
Noncash compensation 27 27 29
Changes in operating assets and liabilities:      
Accounts and notes receivable 103 146 (313)
Inventories 125 (6) (342)
Receivable associated with the Albemarle Settlement 0 333 (333)
Other current assets 31 (51) 47
Other noncurrent assets 60 (52) (189)
Accounts payable (223) (84) 343
Accrued liabilities (31) (297) 292
Other noncurrent liabilities (222) (53) 78
Net cash provided by operating activities from continuing operations 253 895 918
Net cash (used in) provided by operating activities from discontinued operations (42) 22 37
Net cash provided by operating activities 211 917 955
Investing activities:      
Capital expenditures (230) (272) (326)
Cash received from sale of businesses, net 544 0 43
Acquisition of businesses, net of cash acquired 0 0 (245)
Insurance proceeds for recovery of property damage 0 5 8
Other, net (4) 7 13
Net cash provided by (used in) investing activities from continuing operations (42) (1,277) (710)
Net cash used in investing activities from discontinued operations (4) (19) (16)
Net cash provided by (used in) investing activities (46) (1,296) (726)
Increase in receivable from affiliate (352) (1,017) (203)
Financing activities:      
Net (repayments) borrowings on revolving loan facilities (51) 219 (8)
Proceeds from issuance of long-term debt 0 0 447
Repayments of long-term debt (11) (12) (990)
Costs of early extinguishment of debt 0 0 (26)
Distributions paid to noncontrolling interests (36) (16) (40)
Other, net (1) (1) (3)
Net cash used in financing activities (271) 22 (778)
Effect of exchange rate changes on cash (8) (28) (3)
Decrease in cash and cash equivalents (114) (385) (552)
Cash and cash equivalents at beginning of period 654 1,039 1,591
Cash and cash equivalents at end of period 540 654 1,039
Dividends paid to parent (172) (168) (158)
Supplemental cash flow information:      
Cash paid for interest 68 66 82
Cash paid for income taxes $ 97 $ 194 $ 106